HomeACIU • NASDAQ
add
AC Immune SA
Previous close
$1.57
Day range
$1.56 - $1.75
Year range
$1.43 - $4.98
Market cap
171.70M USD
Avg Volume
155.64K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 990.00K | — |
Operating expense | 4.44M | -9.36% |
Net income | -19.03M | -6.53% |
Net profit margin | -1.92K | — |
Earnings per share | -0.19 | -5.56% |
EBITDA | -19.01M | 3.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 145.61M | 38.92% |
Total assets | 211.08M | 26.18% |
Total liabilities | 116.28M | 414.53% |
Total equity | 94.80M | — |
Shares outstanding | 100.41M | — |
Price to book | 1.67 | — |
Return on assets | -21.91% | — |
Return on capital | -44.49% | — |
Cash Flow
Net change in cash
| (CHF) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -19.03M | -6.53% |
Cash from operations | -18.82M | -1,937.50% |
Cash from investing | 3.03M | 112.85% |
Cash from financing | -258.00K | 62.50% |
Net change in cash | -16.32M | 24.06% |
Free cash flow | -11.95M | -265.34% |
About
Founded
2003
Website
Employees
153
